Targeted hepatitis tests costing between ₹3,700 and ₹10,000 can significantly aid in the early detection of liver damage, preventing severe conditions like fibrosis and cirrhosis. Dr. Bimlesh Dhar Pandey, Director of Rheumatology at Fortis Hospital in Noida, emphasizes the importance of selecting the right tests based on clinical judgment rather than conducting blanket screenings. Symptoms such as persistent fatigue, unexplained joint pain, and skin rashes should prompt testing. Early diagnosis of liver diseases, including hepatitis B and C, is crucial for effective treatment and avoiding complications like liver failure. With rising lifestyle-related diseases in India, including diabetes and fatty liver disease, timely evaluation of liver health is becoming increasingly vital. Screening also plays a key role before starting immunosuppressive therapies to prevent the reactivation of untreated viral hepatitis. Ultimately, the focus should be on informed, symptom-based evaluations to ensure better health outcomes.